NYXH
NyxoahNYXH
NYXH
0
Funds holding %
of 6,780 funds
0
Analysts bullish %
of 3 analysts
Fund manager confidence
Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)
33% more repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 3
33% more capital invested
Capital invested by funds: $29.4M [Q2] → $39.1M (+$9.75M) [Q3]
0.37% less ownership
Funds ownership: 12.32% [Q2] → 11.95% (-0.37%) [Q3]
5% less funds holding
Funds holding: 21 [Q2] → 20 (-1) [Q3]
20% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 5
Research analyst outlook
3 Wall Street Analysts provided 1 year price targets over the past 3 months
Low target
$16
96%
upside
Avg. target
$17
109%
upside
High target
$18
121%
upside
3 analyst ratings
3 positive
100%
0 neutral
0%
0 negative
0%
Cantor Fitzgerald Ross Osborn 58% 1-year accuracy 21 / 36 met price target | 96%upside $16 | Overweight Reiterated | 5 Nov 2024 |
HC Wainwright & Co. Edward White 28% 1-year accuracy 35 / 124 met price target | 109%upside $17 | Buy Maintained | 11 Oct 2024 |
HC Wainwright & Co. Edward White 28% 1-year accuracy 35 / 124 met price target | 121%upside $18 | Buy Reiterated | 30 Sept 2024 |
Financial journalist opinion
Based on 6 articles about NYXH published over the past 30 days
Neutral
GlobeNewsWire
1 week ago
Nyxoah to Participate in the Piper Sandler 36th Annual Healthcare Conference
Nyxoah to Participate in the Piper Sandler 36 th Annual Healthcare Conference
Neutral
GlobeNewsWire
2 weeks ago
Invitation to attend the special shareholders' meeting of the Company to be held on December 19, 2024
REGULATED INFORMATION November 19, 2024, 7:00am CET / 1:00am ET NYXOAH SA (Euronext Brussels/Nasdaq: NYXH) Rue Edouard Belin 12, 1435 Mont-Saint-Guibert, Belgium(hereinafter the “Company”) Invitation to attend the special shareholders' meeting of the Company to be held on December 19, 2024 The board of directors of the Company is pleased to invite its securities holders to attend the special shareholders' meeting of the Company, to be held on Thursday, December 19, 2024 at 3:00 p.m. CET at the Company's seat, or at such other place as will be indicated prior to such time.
Neutral
GlobeNewsWire
2 weeks ago
Publication relating to transparency notifications
REGULATED INFORMATION Publication relating to transparency notifications Mont-Saint-Guibert (Belgium), November 18, 2024 , 10:30 pm CET / 4:30 pm ET – In accordance with article 14 of the Act of 2 May 2007 on the disclosure of large shareholdings, Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) announces that it received a transparency notification as detailed below. On November 15, 2024, Nyxoah received a transparency notification from ResMed Inc. following the passive crossing of a threshold.
Neutral
Seeking Alpha
3 weeks ago
Nyxoah S.A. (NYXH) Q3 2024 Earnings Call Transcript
Nyxoah S.A. (NASDAQ:NYXH ) Q3 2024 Earnings Conference Call November 6, 2024 4:30 PM ET Company Participants Mikaela Kirkwood - Corporate Communications and IR Manager Olivier Taelman - CEO Loic Moreau - CFO Conference Call Participants Adam Maeder - Piper Sandler Joe Federico - Stifel Suraj Kalia - Oppenheimer Ross Osborn - Cantor Fitzgerald David Rescott - Baird Operator Good day.
Negative
Zacks Investment Research
3 weeks ago
Nyxoah SA (NYXH) Reports Q3 Loss, Tops Revenue Estimates
Nyxoah SA (NYXH) came out with a quarterly loss of $0.68 per share versus the Zacks Consensus Estimate of a loss of $0.46. This compares to loss of $0.29 per share a year ago.
Neutral
GlobeNewsWire
4 weeks ago
Nyxoah Appoints John Landry as Chief Financial Officer
Nyxoah Appoints John Landry as Chief Financial Officer Current CFO, Loïc Moreau, to Transition into Role of President International Mont-Saint-Guibert, Belgium – November 4, 2024, 10:45pm CET / 4:45pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a medical technology company that develops breakthrough treatment alternatives for Obstructive Sleep Apnea (OSA) through neuromodulation, today announced the appointment of John Landry as Chief Financial Officer (CFO), effective November 4, 2024. This strategic appointment, in combination with the recent move to the United States of CEO Olivier Taelman, strengthens the Company's focus on the U.S. market.
Positive
Zacks Investment Research
1 month ago
Nyxoah SA (NYXH) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release
Nyxoah (NYXH) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Neutral
GlobeNewsWire
1 month ago
Publication relating to transparency notifications
REGULATED INFORMATION Publication relating to transparency notifications Mont-Saint-Guibert (Belgium), October 25, 2024 , 10:30 pm CET / 4:30 pm ET – In accordance with article 14 of the Act of 2 May 2007 on the disclosure of large shareholdings, Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) announces that it received a transparency notification as detailed below. Vestal Point Capital On October 23, 2024, Nyxoah received a transparency notification from Vestal Point Capital following an acquisition or disposal of voting securities or voting rights.
Neutral
GlobeNewsWire
1 month ago
Nyxoah to Release Third Quarter 2024 Financial Results on November 6, 2024
Nyxoah to Release Third Quarter 2024 Financial Results on November 6, 2024 Mont-Saint-Guibert, Belgium – October 22, 2024, 10:30pm CET / 4:30pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea (OSA), today announced that the Company will release financial results for the third quarter 2024 on Wednesday, November 6, 2024, after market close. Company management will host a conference call to discuss financial results that day beginning at 10:30pm CET / 4:30pm ET.
Neutral
GlobeNewsWire
1 month ago
Publication relating to transparency notifications
REGULATED INFORMATION Publication relating to transparency notifications Mont-Saint-Guibert (Belgium), October 15, 2024 , 10:30 pm CET / 4:30 pm ET – In accordance with article 14 of the Act of 2 May 2007 on the disclosure of large shareholdings, Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) announces that it received three transparency notifications as detailed below. Jürgen Hambrecht On October 15, 2024, Nyxoah received a transparency notification from Jürgen Hambrecht and Jürgen Hambrecht's controlled undertaking JH Capital GmbH following an acquisition or disposal of voting securities or voting rights.
Charts implemented using Lightweight Charts™